Clinical Trials on Serous Ovarian Cancer
Total 136821 results
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
CanariaBio Inc.Veristat, LLCActive, not recruitingPeritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Epithelial Cancer of Ovary | Recurrent Epithelial Ovarian Cancer | Recurrent Carcinoma of Ovary | Adenocarcinoma of OvaryUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingOvarian CarcinomaUnited States, Korea, Republic of
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsSarcoma | Glioblastoma | Recurrent Ovarian Carcinoma | Recurrent Uterine Corpus Carcinoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Metastatic Renal Cell Cancer | Recurrent Lung Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage... and other conditionsUnited States
-
Medical University of LublinCompletedOvarian Cancer | Unexplained Infertility | Borderline Ovarian Tumors | Benign Ovarian TumorPoland
-
Affiliated Cancer Hospital & Institute of Guangzhou...Chongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaboratorsRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaChina
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Shu-Zhong CuiXiangya Hospital of Central South University; Wuhan University; Peking University... and other collaboratorsUnknownFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaChina
-
The Affiliated Hospital of the Chinese Academy...Recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Shandong UniversityRecruitingObjective Response RateChina
-
Uppsala University HospitalUppsala University; The Netherlands Cancer InstituteRecruitingOvarian Cancer RecurrentSweden
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruitingPlatinum-sensitive Relapsed Ovarian CancerChina
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Belgium, Czechia, Germany
-
National Cancer Centre, SingaporeCompleted
-
Ayana Pharma Ltd.,Lambda Therapeutic Research Ltd.CompletedOvarian Cancer RecurrentIndia
-
Centre Francois BaclesseLigue contre le cancer, France; Fondation de FranceCompleted
-
ARCAGY/ GINECO GROUPCompletedOvarian Cancer RecurrentFrance
-
Priv.-Doz. Dr. med. Joachim RomCompletedEpithelial Ovarian CancerGermany
-
National Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Leiden University Medical CenterUniversity Medical Center GroningenCompletedRecurrent Ovarian CancerNetherlands
-
Wuhan UniversityUnknown
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...Unknown
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)
-
UNICANCERActive, not recruitingOvarian Epithelial Cancer RecurrentFrance, Belgium, Spain
-
University Hospital, RouenCompletedBreast Cancer | Colorectal Cancer | Ovarian Cancer | Pediatric Cancers | Multiple Primary Malignant TumoursFrance
-
NewVac LLCJanssen Pharmaceutica N.V., BelgiumCompletedEpithelial Ovarian Cancer | Non-small Cell Lung CancerRussian Federation
-
GOG FoundationGlaxoSmithKlineRecruitingStage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage IV Primary Peritoneal Cancer | Stage III Ovarian Cancer | Stage III Primary Peritoneal Cancer | Stage III Fallopian Tube CancerUnited States
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
OnxeoRecruitingBreast Cancer | Metastatic Castration-resistant Prostate Cancer | Recurrent Epithelial Ovarian CancerUnited States
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Belgium, Spain, Israel, Australia, Ireland, Germany, Italy, Bulgaria, Czechia, Poland
-
Hospices Civils de LyonCompletedSerous Ovarian Carcinoma | Low Grade Serous Ovarian CarcinomaFrance
-
ARCAGY/ GINECO GROUPCompleted
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent Platinum-resistant Ovarian CancerChina
-
Haukeland University HospitalHelse Stavanger HF; Sorlandet Hospital HFRecruiting
-
Marker Therapeutics, Inc.TerminatedOvarian Cancer | Platinum Sensitive Ovarian CancerUnited States
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
National Cancer Center, KoreaAjou UniversityCompletedEpithelial Ovarian CancerKorea, Republic of
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
PEDRO VILLAREJO CAMPOSUniversity of Castilla-La Mancha; Hospital General de Ciudad RealUnknownEpithelial Ovarian CancerSpain
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany
-
Dr. Reddy's Laboratories LimitedCompletedOvarian Epithelial Cancer RecurrentIndia
-
Esperance Pharmaceuticals IncCompletedOvarian Cancer RecurrentUnited States